LivaNova PLC

Ownership Transactions Reported by 23 Insiders

Symbol
LIVN on Nasdaq
Location
20 Eastbourne Terrace, London, United Kingdom

Insiders trading volume in the past year

LivaNova PLC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Damien McDonald CEO, Director $5.79M Mar 30, 2023
Daniel J. Moore Director $1.81M -$3.4M -65.3% Jun 3, 2024
William A. Kozy Director $1.77M Jun 15, 2024
Vladimir Makatsaria Chief Executive Officer, Director $1.31M Mar 30, 2024
Arthur L. Rosenthal Director $1.22M Jun 15, 2022
Trui Hebbelinck Chief Human Resources Officer $991K Mar 30, 2024
Alex Shvartsburg Cfo $987K Jun 15, 2024
Stephanie Bolton President, Global Epilepsy $804K Mar 30, 2024
Francesco Bianchi Director $728K Jun 15, 2024
Sharon O'Kane Director $687K Jun 15, 2024
Marco Dolci President CP $682K Mar 30, 2023
Alfred J. Novak Director $653K Jun 15, 2022
Ahmet Tezel Chief Innovation Officer $650K Jun 15, 2024
Seng Stacy Enxing Director $648K Jun 15, 2024
Andrea Lynn Saia Director $559K Dec 31, 2023
Todd C. Schermerhorn Director $506K Jun 15, 2024
Michael Damon Hutchinson Chief Legal Officer $446K Mar 30, 2024
Keyna Pidcock Skeffington General Counsel $419K Sep 15, 2022
Peter M. Wilver Director $384K Jun 15, 2024
Brooke Story Director $370K Jun 15, 2024
Franco Poletti President, Cardiopulmonary $351K Aug 1, 2024
Hugh M. Morrison Director $272K Jun 29, 2021
James Christopher Barry Director $187K Jun 15, 2024

Recent Insider Transactions by Companies or Individuals for LivaNova PLC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.